Polyglutamine (polyQ) expansion in huntingtin (htt) underlies Huntington's disease (HD). The mechanisms which cause neuron dysfunction and degeneration in HD are unknown. To identify HD-associated pathways, we have undertaken a C. elegans-based study that relies on two approaches: screening for proteins able to interact with htt, and screening for genetic suppressors of mutated htt-dependent phenotypes in transgenic worms. We used the
mec-3 promoter (
mec-3p) to express GFP fusions which contain a short N-terminal fragment of htt with a normal (17 units) or expanded (84 units) polyQ tract. The
mec-3 gene is expressed in 10 neurons including the six touch receptor neurons AVM, ALML, ALMR, PVM, PLML and PLMR. Worms expressing the long polyQ construct were less than 30% and 50% Mec at the tail at Day 1 and 7, respectively. Worms expressing the short polyQ construct or animals with GFP expression driven by
mec-3p were less than 7% and 30% Mec at the tail over the same time-frame. Cell death was not observed in these experiments. There was an imperfect correlation between the perinuclear aggregation of GFP fusions in PLM cells and the Mec phenotypes observed. Our preliminary data suggest that N-terminal htt fragments with a long polyQ induce touch insensitivity when expressed in touch receptor neurons, and that transgenic worms expressing mutated htt might be useful for screening for genetic suppressors of behavioural phenotypes. We have screened a C. elegans cDNA library (R. Barstead, OMRC, OK) by using two-hybrid selection in yeast. The screening with a N-terminal htt fragment containing 15 Glns allowed the identification of a new Htt Interacting Protein (wHIP3). WHIP3 shows variation of interaction between normal and mutated htt, and is homologous with a human protein (hHIP3) encoded by a gene expressed in the brain. Additional studies are being performed in order to test whether hHIP3 might be involved in HD. We will present the results of experiments based on both approaches.